AOD-9604
Anti-Obesity Drug Fragment
Focused on fat metabolism and lipolysis. A non-hormonal approach to weight management.
Ships to All 50 States · Free Shipping Over $150 · COA Included With Every Order
Dual GIP/GLP-1 Agonist
Targets both GIP and GLP-1 receptors, supporting metabolic health, weight loss, and glucose balance.
For research use only. Not intended for human or veterinary use, diagnosis, treatment, or cure of any condition. Questions? Contact us.
Independent third-party testing on every batch.
A Certificate of Analysis for Tirzepatide, matching the exact batch you receive, is included with every order. Need the COA for a specific lot in advance? Email support@pepthority.com.
Anti-Obesity Drug Fragment
Focused on fat metabolism and lipolysis. A non-hormonal approach to weight management.
GLP-1 Receptor Agonist
Supports appetite regulation, insulin sensitivity, and weight management through GLP-1 receptor activity.
Triple Agonist
An advanced tri-agonist targeting three metabolic receptors simultaneously for fat regulation and metabolic support.
Body Protection Compound
Supports tissue repair, wound healing, tendon and ligament recovery, gut health, and reducing inflammation.